Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Thalmann

Showing results (51-60 of 307) with videos related to

Pageof 31
Sort By:
Histopathology|March 16, 2011
Extracapsular extension but not the tumour burden of lymph node metastases is an independent adverse risk factor in lymph node-positive bladder cancerRoland Seiler, Michael von Gunten, George N Thalmann, et al.
BJU International|April 28, 2023
The BJUI Editorial Team's view on artificial intelligence and machine learningGeorge N Thalmann, Tobias Klatte, Nathan Papa, et al.
BJU International|March 19, 2013
Novel prototype sewing device, EndoSew®, for minimally invasive surgery: an extracorporeal ileal conduit construction pilot study in 10 patientsBeat Roth, Frédéric D Birkhäuser, George N Thalmann, et al.
Emergency Medicine International|November 3, 2011
Lunar tractive forces and renal stone incidenceSpyridon Arampatzis, George N Thalmann, Heinz Zimmermann, et al.
Urological Research|January 1, 1997
Immunohistochemical determination of p53 overexpression. An easy and readily available method to identify progression in superficial bladder cancer?F C Burkhard, R Markwalder, G N Thalmann, et al.
European Urology|December 18, 2021
Re: Impact of the Implementation of the EAU Guidelines Recommendation on Reporting and Grading of Complications in Patients Undergoing Robot-assisted Radical Cystectomy: A Systematic ReviewNiranjan J Sathianathen, Nathan Lawrentschuk, George N Thalmann, et al.
BJU International|February 1, 2005
Is pelvic lymphadenectomy really necessary in patients with a serum prostate-specific antigen level of <10 ng/ml undergoing radical prostatectomy for prostate cancer?Fiona C Burkhard, Martin Schumacher, George N Thalmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2004
Is eligibility for a chemotherapy protocol a good prognostic factor for invasive bladder cancer after radical cystectomy?Stephan Madersbacher, George N Thalmann, Johannes C Fritsch, et al.
Cancers|July 17, 2020
The Role of Cancer-Associated Fibroblasts in Prostate Cancer TumorigenesisFrancesco Bonollo, George N Thalmann, Marianna Kruithof-de Julio, et al.
BJU International|February 17, 2025
Case of the month from University Hospital Bern, Switzerland: bladder tumour with extreme leucocytosisAmir Naiem, Gallus Beatus Ineichen, Antonio Rodriguez Calero, et al.
Pageof 31

Showing results (51-60 of 307) with videos related to

Sort By:
Pageof 31
Histopathology|March 16, 2011
Extracapsular extension but not the tumour burden of lymph node metastases is an independent adverse risk factor in lymph node-positive bladder cancerRoland Seiler, Michael von Gunten, George N Thalmann, et al.
BJU International|April 28, 2023
The BJUI Editorial Team's view on artificial intelligence and machine learningGeorge N Thalmann, Tobias Klatte, Nathan Papa, et al.
BJU International|March 19, 2013
Novel prototype sewing device, EndoSew®, for minimally invasive surgery: an extracorporeal ileal conduit construction pilot study in 10 patientsBeat Roth, Frédéric D Birkhäuser, George N Thalmann, et al.
Emergency Medicine International|November 3, 2011
Lunar tractive forces and renal stone incidenceSpyridon Arampatzis, George N Thalmann, Heinz Zimmermann, et al.
Urological Research|January 1, 1997
Immunohistochemical determination of p53 overexpression. An easy and readily available method to identify progression in superficial bladder cancer?F C Burkhard, R Markwalder, G N Thalmann, et al.
European Urology|December 18, 2021
Re: Impact of the Implementation of the EAU Guidelines Recommendation on Reporting and Grading of Complications in Patients Undergoing Robot-assisted Radical Cystectomy: A Systematic ReviewNiranjan J Sathianathen, Nathan Lawrentschuk, George N Thalmann, et al.
BJU International|February 1, 2005
Is pelvic lymphadenectomy really necessary in patients with a serum prostate-specific antigen level of <10 ng/ml undergoing radical prostatectomy for prostate cancer?Fiona C Burkhard, Martin Schumacher, George N Thalmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2004
Is eligibility for a chemotherapy protocol a good prognostic factor for invasive bladder cancer after radical cystectomy?Stephan Madersbacher, George N Thalmann, Johannes C Fritsch, et al.
Cancers|July 17, 2020
The Role of Cancer-Associated Fibroblasts in Prostate Cancer TumorigenesisFrancesco Bonollo, George N Thalmann, Marianna Kruithof-de Julio, et al.
BJU International|February 17, 2025
Case of the month from University Hospital Bern, Switzerland: bladder tumour with extreme leucocytosisAmir Naiem, Gallus Beatus Ineichen, Antonio Rodriguez Calero, et al.
Pageof 31